ORIC· Oric Pharmaceuticals Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 1 | $703K |
Quarterly ownership history
Last 4 quarters
ORIC Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$916M
Enterprise value$641M
EV / EBITDA (TTM)-4.31
P/E ratio (TTM)—
Forward P/E-5.79
P/S ratio—
P/B ratio2.27
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$111M
Free cash flow (TTM)-$68M
Total cash$282M
Total debt$7M
Debt / equity1.62
Current ratio16.33
Income Statement
Total revenue (TTM)—
Revenue per share (TTM)—
Gross profit (TTM)—
EBITDA (TTM)-$149M
Net income (TTM)-$135M
EPS diluted (TTM)-1.39
Shares outstanding103,517,562
Float shares70,726,304
Profitability
Gross margin0.00%
Operating margin0.00%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-27.57%
Return on equity (TTM)-42.57%
Price History
Current price$8.85
52 Week high$14.93
52 Week low$4.54
50 day average$10.94
200 day average$10.96
Average volume (10 day)1,360,850
1-year beta1.10
1-year price target$20.77
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:40 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com